{"nct_id":"NCT06428396","title":"Study of Belzutifan (MK-6482) Plus Fulvestrant for ER+/HER2- Metastatic Breast Cancer (MK-6482-029/LITESPARK-029)","status":"RECRUITING","status_verified_date":"2025-09","start_date":"2024-11-27","start_date_type":"ACTUAL","primary_completion_date":"2027-05-05","primary_completion_date_type":"ESTIMATED","completion_date":"2028-10-07","completion_date_type":"ESTIMATED","phases":["PHASE2"],"tickers":["MRK"]}